Q4 2017 Holdings
Filed 2018-02-14 | 74 holdings | $51.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aveo Pharmaceuticals Inc(AVEOEUR)Call | COM | 053588109 | $33 | 12,000 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA)Put | COM | 60877T100 | $35 | 2,500 | 0.0% |
| Oncobiologics Inc | COM | 68235M105 | $38 | 29,082 | 0.0% |
| TG Therapeutics Inc(TGTX)Call | COM | 88322Q108 | $82 | 10,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA)Call | COM | 462260100 | $88 | 11,000 | 0.0% |
| Transenterix IncPut | COM NEW | 89366M201 | $203 | 105,000 | 0.0% |
| Neos Therapeutics Inc(NEOS)Put | COM | 64052L106 | $255 | 25,000 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX)Put | COM NEW | 528872302 | $321 | 32,500 | 0.0% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | COM | 053588109 | $347 | 124,338 | 0.0% |
| Evolent Health Inc(EVH)Call | CL A | 30050B101 | $400 | 32,500 | 0.0% |
| Mannkind Corp(MNKD)Put | COM NEW | 56400P706 | $400 | 172,500 | 0.0% |
| Spark Therapeutics IncPut | COM | 84652J103 | $514 | 10,000 | 0.0% |
| Mimedx Group Inc(MDXG)Put | COM | 602496101 | $631 | 50,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $632 | 43,900 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA)Call | COM | 60877T100 | $646 | 46,300 | 0.0% |
| Evertec Inc(EVTC)Put | COM | 30040P103 | $751 | 55,000 | 0.0% |
| Glaukos Corp(GKOS)Put | COM | 377322102 | $795 | 31,000 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX)Put | COM | 046513107 | $996 | 55,000 | 0.0% |
| Immune Design Corp | COM | 45252L103 | $1.1K | 274,100 | 0.0% |
| Medicines CoCall | COM | 584688105 | $1.1K | 40,000 | 0.0% |
| Viewray Inc(VRAYQ)Call | COM | 92672L107 | $1.1K | 120,000 | 0.0% |
| Five Prime Therapeutics Inc(FPRX)Put | COM | 33830X104 | $1.2K | 52,500 | 0.0% |
| Neos Therapeutics Inc(NEOS)Call | COM | 64052L106 | $1.2K | 115,500 | 0.0% |
| Editas Medicine Inc(EDIT)Put | COM | 28106W103 | $1.2K | 40,000 | 0.0% |
| Alimera Sciences Inc | COM | 016259103 | $1.3K | 974,318 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $1.4K | 152,300 | 0.0% |
| Teladoc Inc(TDOC)Put | COM | 87918A105 | $1.4K | 40,000 | 0.0% |
| Exelixis Inc(EXEL)Call | COM | 30161Q104 | $1.5K | 50,000 | 0.0% |
| Seattle Genetics IncPut | COM | 812578102 | $1.6K | 30,000 | 0.0% |
| Stemline Therapeutics IncCall | COM | 85858C107 | $1.6K | 105,000 | 0.0% |
| Intellia Therapeutics Inc(NTLA)Call | COM | 45826J105 | $1.7K | 86,000 | 0.0% |
| Juno Therapeutics IncCall | COM | 48205A109 | $1.7K | 37,000 | 0.0% |
| Amag Pharmaceuticals Inc(AMAG)Put | COM | 00163U106 | $1.8K | 132,500 | 0.0% |
| Nektar Therapeutics(NKTREUR)Put | COM | 640268108 | $1.8K | 30,000 | 0.0% |
| Crispr Therapeutics AG(CRSP)Call | NAMEN AKT | H17182108 | $1.9K | 80,000 | 0.0% |
| Orasure Technologies Inc(OSUR)Put | COM | 68554V108 | $1.9K | 100,000 | 0.0% |
| Editas Medicine Inc(EDIT)Call | COM | 28106W103 | $2.0K | 64,000 | 0.0% |
| Valeant Pharmaceuticals IntlCall | COM | 91911K102 | $2.1K | 100,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE)Call | COM | 90400D108 | $2.1K | 46,000 | 0.0% |
| Nektar Therapeutics(NKTREUR)Call | COM | 640268108 | $2.2K | 36,000 | 0.0% |
| Viveve MED Inc | COM NEW | 92852W204 | $2.2K | 433,419 | 0.0% |
| Agios Pharmaceuticals Inc(AGIO)Put | COM | 00847X104 | $2.3K | 40,000 | 0.0% |
| Acadia Pharmaceuticals Inc(ACAD)Call | COM | 004225108 | $2.4K | 80,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | COM | 31447P100 | $2.5K | 250,000 | 0.0% |
| Loxo Oncology IncPut | COM | 548862101 | $2.5K | 30,000 | 0.0% |
| Rockwell MED IncPut | COM | 774374102 | $2.6K | 440,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $2.8K | 155,000 | 0.0% |
| Global Blood Therapeutics inCall | COM | 37890U108 | $3.1K | 80,000 | 0.0% |
| Nabriva Therapeutics PLC | SHS | G63637105 | $3.5K | 580,000 | 0.0% |
| CAS MED SYS Inc | COM PAR | 124769209 | $4.0K | 5,160,000 | 0.0% |